Amylyx Pharmaceuticals Etf Price on August 29, 2024
| AMLX Etf | USD 5.53 0.00 0.00% |
If you're considering investing in Amylyx Etf, it is important to understand the factors that can impact its price. As of today, the current price of Amylyx Pharmaceuticals stands at 5.53, as last reported on the 29th of November, with the highest price reaching 5.85 and the lowest price hitting 5.32 during the day. Amylyx Pharmaceuticals is slightly risky given 3 months investment horizon. Amylyx Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.29, which signifies that the etf had a 0.29% return per unit of risk over the last 3 months. We were able to break down and interpolate twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.63% are justified by taking the suggested risk. Use Amylyx Pharmaceuticals Downside Deviation of 5.01, risk adjusted performance of 0.2359, and Mean Deviation of 4.33 to evaluate company specific risk that cannot be diversified away.
Amylyx Etf price history is provided at the adjusted basis, taking into account all of the recent filings.
Amylyx |
Sharpe Ratio = 0.2871
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | AMLX | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.69 actual daily | 50 50% of assets are less volatile |
Expected Return
| 1.63 actual daily | 32 68% of assets have higher returns |
Risk-Adjusted Return
| 0.29 actual daily | 22 78% of assets perform better |
Based on monthly moving average Amylyx Pharmaceuticals is performing at about 22% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amylyx Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 2.0054 | Enterprise Value Ebitda (11.71) | Price Sales 2.0025 | Shares Float 42.2 M | Wall Street Target Price 7.5 |
Related Headline
Ensysce Biosciences Headline on 29th of August 2024
Diamond Equity Research Releases Update Note on Ensysce Bios... by finance.yahoo.com
New York, NY, Aug. 29, 2024 -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on Ensysce Biosciences, Inc. . The update note includes information on Ensysce Biosciences business model, services, industry, financial results, valuation, and risks. The update note is available here. Ensysce August 2024 Note Highlights from the note include NIH and NIDA Award 14 Million Grant
Amylyx Pharmaceuticals Valuation on August 29, 2024
It is possible to determine the worth of Amylyx Pharmaceuticals on a given historical date. On August 29, 2024 Amylyx was worth 2.1 at the beginning of the trading date compared to the closed value of 2.12. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Amylyx Pharmaceuticals etf. Still, in general, we apply an absolute valuation method to find Amylyx Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Amylyx Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Amylyx Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 2.11 | 2.16 | 2.05 | 2.09 | 578,503 | |
08/29/2024 | 2.10 | 2.16 | 2.09 | 2.12 | 380,671 |
| 2.11 | 2.23 | 2.09 | 2.22 | 414,190 |
| Backtest Amylyx Pharmaceuticals | | | Amylyx Pharmaceuticals History | | | Amylyx Pharmaceuticals Valuation | Previous | Next |
Amylyx Pharmaceuticals Trading Date Momentum on August 29, 2024
| On August 30 2024 Amylyx Pharmaceuticals was traded for 2.22 at the closing time. The top price for the day was 2.23 and the lowest listed price was 2.09 . The trading volume for the day was 414.2 K. The trading history from August 30, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 4.72% . The overall trading delta against the current closing price is 10.38% . |
Amylyx Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Amylyx Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Amylyx Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Amylyx financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Amylyx Pharmaceuticals Etf history
Amylyx Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Amylyx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Amylyx Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Amylyx Pharmaceuticals stock prices may prove useful in developing a viable investing in Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals is listed under Biotechnology in the United States and is traded on NASDAQ Exchange exchange.
Amylyx Pharmaceuticals Quarterly Net Working Capital |
|
Amylyx Pharmaceuticals Etf Technical Analysis
Amylyx Pharmaceuticals technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
Price Boundaries
Amylyx Pharmaceuticals Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Amylyx Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Amylyx Pharmaceuticals November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Amylyx Pharmaceuticals etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Amylyx Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Amylyx Pharmaceuticals etf market strength indicators, traders can identify Amylyx Pharmaceuticals entry and exit signals to maximize returns
Amylyx Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Amylyx Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Amylyx Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of Amylyx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.2359 | |||
| Jensen Alpha | 1.51 | |||
| Total Risk Alpha | 0.8095 | |||
| Sortino Ratio | 0.307 | |||
| Treynor Ratio | 1.33 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Amylyx Etf
Amylyx Pharmaceuticals financial ratios help investors to determine whether Amylyx Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amylyx with respect to the benefits of owning Amylyx Pharmaceuticals security.